is hers semaglutide fda approved Telehealth company Hims & cancels $49 monthly weight loss drug launch following warnings about unapproved compounds and Novo threats Despite FDA ruling, compounded GLP-1s

Liraglutide modulates GABAergic signaling in rat hippocampal CA3 pyramidal neurons predominantly by presynaptic mechanism

Other documented adverse effects include injection site reactions, fatigue, dizziness, and headache

Semaglutide's approval was based on clinical trial data showing approximately 15% weight loss over 68 weeks, results that were considered groundbreaking at the time and established GLP-1 receptor agonists as legitimate obesity treatments [14]

In rats, more severe effects were seen after maternal exposure to semaglutide in the form of visceral abnormalities and major skeletal malformations ( Table 1 )